Briganti and colleagues concluded that, together with the main PROTEUS study, the substudy supports 1-year perioperative apalutamide plus ADT as a treatment option for patients with high-risk ...

In the early-stage trial, 77% of 31 evaluable patients receiving the 50-milligram dose experienced a PSA decline of at least ...

Positive results from the VOLGA Phase III trial showed perioperative treatment with AstraZeneca’s IMFINZI® (durvalumab) in combination with neoadjuvant enfortumab vedotin (EV) demonstrated ...

Kochi, Oct 24 (PTI) Kochi, Oct 24 (PTI) Sudden testicular pain in boys and adolescents should be treated as a medical emergency, as delays can cause irreversible damage and loss of the testis, urologi ...

A 25 year old woman who had lived with liver cirrhosis since childhood underwent a successful liver transplant at CARE Hospitals, Banjara Hills, Hyderabad. A specialised desensitization protocol ...

Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of apalutamide plus androgen deprivation therapy (ADT), given ...

Johnson & Johnson on Saturday said its experimental once-daily oral prostate cancer drug caused ​tumors to disappear or shrink in an early-stage ‌trial.

A cancer diagnosis is hard enough without a long journey for treatment. That was the message from Janet Finch-Saunders MS, who raised concerns in the Senedd this week about prostate cancer care in ...

Pope Leo was seen ahead of his first general audience since undergoing cancer surgery. Watch video from Vatican Media.